Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)

NACompletedINTERVENTIONAL
Enrollment

536

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Pneumonia Childhood
Interventions
BEHAVIORAL

Clinical Decision Support

For enrolled subjects assigned to the decision support arm, providers will receive prognostic information derived using our previously validated and best performing model. The decision support application will automatically calculate predicted risk for moderate (intensive care) and severe (respiratory failure or shock) outcomes using the parameters derived from the prognostic tool's regression equation. Outcome probabilities will be integrated into the decision support application and displayed within the EHR.

Trial Locations (1)

37232

Monroe Carell Jr. Children's Hospital - Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Pittsburgh Medical Center

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT06033079 - Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2) | Biotech Hunter | Biotech Hunter